Literature DB >> 27754946

Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.

Steven Swiryn1, Michael V Orlov2, David G Benditt2, John P DiMarco2, Donald M Lloyd-Jones2, Edward Karst2, Fujian Qu2, Mara T Slawsky2, Melanie Turkel2, Albert L Waldo2.   

Abstract

BACKGROUND: The RATE Registry (Registry of Atrial Tachycardia and Atrial Fibrillation Episodes) is a prospective, outcomes-oriented registry designed to document the prevalence of atrial tachycardia and/or fibrillation (AT/AF) of any duration in patients with pacemakers and implantable cardioverter defibrillators (ICDs) and evaluate associations between rigorously adjudicated AT/AF and predefined clinical events, including stroke. The appropriate clinical response to brief episodes of AT/AF remains unclear.
METHODS: Rigorously adjudicated electrogram (EGM) data were correlated with adjudicated clinical events with logistic regression and Cox models. Long episodes of AT/AF were defined as episodes in which the onset and/or offset of AT/AF was not present within a single EGM recording. Short episodes of AT/AF were defined as episodes in which both the onset and offset of AT/AF were present within a single EGM recording.
RESULTS: We enrolled 5379 patients with pacemakers (N=3141) or ICDs (N=2238) at 225 US sites (median follow-up 22.9 months). There were 359 deaths. There were 478 hospitalizations among 342 patients for clinical events. We adjudicated 37 531 EGMs; 50% of patients had at least one episode of AT/AF. Patients with clinical events were more likely than those without to have long AT/AF (31.9% vs. 22.1% for pacemaker patients and 28.7% vs. 20.2% for ICD patients; P<0.05 for both groups). Only short episodes of AT/AF were documented in 9% of pacemaker patients and 16% of ICD patients. Patients with clinical events were no more likely than those without to have short AT/AF (5.1% vs. 7.9% for pacemaker patients and 11.5% vs. 10.4% for ICD patients; P=0.21 and 0.66, respectively).
CONCLUSIONS: In the RATE Registry, rigorously adjudicated short episodes of AT/AF, as defined, were not associated with increased risk of clinical events compared with patients without documented AT/AF. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00837798.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  anti-coagulation; atrial fibrillation; defibrillators; pacemakers; stroke; trials

Mesh:

Year:  2016        PMID: 27754946     DOI: 10.1161/CIRCULATIONAHA.115.020252

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

Review 1.  Atrial cardiopathy: a mechanism of cryptogenic stroke.

Authors:  Shadi Yaghi; Hooman Kamel; Mitchell S V Elkind
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-07-27

2.  Atrial Fibrillation Burden Signature and Near-Term Prediction of Stroke: A Machine Learning Analysis.

Authors:  Lichy Han; Mariam Askari; Russ B Altman; Susan K Schmitt; Jun Fan; Jason P Bentley; Sanjiv M Narayan; Mintu P Turakhia
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-10-15

3.  Impact of atrial fibrillation detected by extended monitoring-A population-based cohort study.

Authors:  Mathias C Busch; Stefan Gross; Dietrich Alte; Jan A Kors; Henry Völzke; Till Ittermann; André Werner; Anne Krüger; Raila Busch; Marcus Dörr; Stephan B Felix
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-04-25       Impact factor: 1.468

Review 4.  Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.

Authors:  Shadi Yaghi; Hooman Kamel
Journal:  Stroke       Date:  2017-09-15       Impact factor: 7.914

Review 5.  Electrical cardioversion of patients with implanted pacemaker or cardioverter-defibrillator: results of a survey of german centers and systematic review of the literature.

Authors:  J Lüker; A Sultan; T Plenge; J van den Bruck; C-H Heeger; S Meyer; K Mischke; R R Tilz; D Vollmann; G Nölker; B Schäffer; S Willems; D Steven
Journal:  Clin Res Cardiol       Date:  2017-11-18       Impact factor: 5.460

6.  2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yu-Feng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-12

7.  Performance of an atrial fibrillation detection algorithm using continuous pulse wave monitoring.

Authors:  Asami Kashiwa; Fumio Koyama; Koji Miyamoto; Tsukasa Kamakura; Mitsuru Wada; Kenichiro Yamagata; Kohei Ishibashi; Yuko Inoue; Hideo Okamura; Satoshi Nagase; Takashi Noda; Takeshi Aiba; Shinichiro Watanabe; Akihiro Goto; Satoshi Yasuda; Kengo Kusano
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-11-02       Impact factor: 1.468

Review 8.  Big Data and Atrial Fibrillation: Current Understanding and New Opportunities.

Authors:  Qian-Chen Wang; Zhen-Yu Wang
Journal:  J Cardiovasc Transl Res       Date:  2020-05-06       Impact factor: 4.132

Review 9.  The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation.

Authors:  Rocco J Cannistraro; James F Meschia
Journal:  Curr Cardiol Rep       Date:  2018-09-12       Impact factor: 2.931

Review 10.  Atrial Cardiopathy and Stroke Prevention.

Authors:  Mitchell S V Elkind
Journal:  Curr Cardiol Rep       Date:  2018-09-12       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.